nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Decreased appetite—Fluorouracil—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Meropenem—Diarrhoea—Sunitinib—pancreatic cancer	0.000772	0.000772	CcSEcCtD
Meropenem—Dysgeusia—Docetaxel—pancreatic cancer	0.000771	0.000771	CcSEcCtD
Meropenem—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000769	0.000769	CcSEcCtD
Meropenem—Abdominal distension—Epirubicin—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Meropenem—Feeling abnormal—Irinotecan—pancreatic cancer	0.000766	0.000766	CcSEcCtD
Meropenem—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000764	0.000764	CcSEcCtD
Meropenem—Asthma—Epirubicin—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Meropenem—Back pain—Docetaxel—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Meropenem—Pain—Fluorouracil—pancreatic cancer	0.000761	0.000761	CcSEcCtD
Meropenem—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00076	0.00076	CcSEcCtD
Meropenem—Eosinophilia—Epirubicin—pancreatic cancer	0.000755	0.000755	CcSEcCtD
Meropenem—Dizziness—Sunitinib—pancreatic cancer	0.000746	0.000746	CcSEcCtD
Meropenem—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000746	0.000746	CcSEcCtD
Meropenem—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000743	0.000743	CcSEcCtD
Meropenem—Abdominal pain—Irinotecan—pancreatic cancer	0.000735	0.000735	CcSEcCtD
Meropenem—Body temperature increased—Irinotecan—pancreatic cancer	0.000735	0.000735	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000735	0.000735	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000735	0.000735	CcSEcCtD
Meropenem—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000734	0.000734	CcSEcCtD
Meropenem—Anaemia—Docetaxel—pancreatic cancer	0.000728	0.000728	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.00072	0.00072	CcSEcCtD
Meropenem—Vomiting—Sunitinib—pancreatic cancer	0.000717	0.000717	CcSEcCtD
Meropenem—Body temperature increased—Gemcitabine—pancreatic cancer	0.000716	0.000716	CcSEcCtD
Meropenem—Neutropenia—Epirubicin—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Meropenem—Dysuria—Epirubicin—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Meropenem—Rash—Sunitinib—pancreatic cancer	0.000711	0.000711	CcSEcCtD
Meropenem—Dermatitis—Sunitinib—pancreatic cancer	0.000711	0.000711	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—pancreatic cancer	0.00071	0.00071	CcSEcCtD
Meropenem—Urticaria—Fluorouracil—pancreatic cancer	0.000707	0.000707	CcSEcCtD
Meropenem—Headache—Sunitinib—pancreatic cancer	0.000707	0.000707	CcSEcCtD
Meropenem—Syncope—Docetaxel—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Meropenem—Asthma—Doxorubicin—pancreatic cancer	0.000705	0.000705	CcSEcCtD
Meropenem—Leukopenia—Docetaxel—pancreatic cancer	0.000705	0.000705	CcSEcCtD
Meropenem—Body temperature increased—Fluorouracil—pancreatic cancer	0.000704	0.000704	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—pancreatic cancer	0.000698	0.000698	CcSEcCtD
Meropenem—Loss of consciousness—Docetaxel—pancreatic cancer	0.000692	0.000692	CcSEcCtD
Meropenem—Cough—Docetaxel—pancreatic cancer	0.000687	0.000687	CcSEcCtD
Meropenem—Hypersensitivity—Irinotecan—pancreatic cancer	0.000685	0.000685	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—pancreatic cancer	0.000683	0.000683	CcSEcCtD
Meropenem—Hypertension—Docetaxel—pancreatic cancer	0.00068	0.00068	CcSEcCtD
Meropenem—Infestation—Epirubicin—pancreatic cancer	0.000679	0.000679	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—pancreatic cancer	0.000679	0.000679	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000674	0.000674	CcSEcCtD
Meropenem—Chest pain—Docetaxel—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Meropenem—Nausea—Sunitinib—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Meropenem—Renal failure—Epirubicin—pancreatic cancer	0.000668	0.000668	CcSEcCtD
Meropenem—Asthenia—Irinotecan—pancreatic cancer	0.000667	0.000667	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000666	0.000666	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000666	0.000666	CcSEcCtD
Meropenem—Jaundice—Epirubicin—pancreatic cancer	0.000662	0.000662	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—pancreatic cancer	0.000659	0.000659	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—pancreatic cancer	0.000659	0.000659	CcSEcCtD
Meropenem—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000656	0.000656	CcSEcCtD
Meropenem—Sweating—Epirubicin—pancreatic cancer	0.000651	0.000651	CcSEcCtD
Meropenem—Asthenia—Gemcitabine—pancreatic cancer	0.00065	0.00065	CcSEcCtD
Meropenem—Confusional state—Docetaxel—pancreatic cancer	0.000648	0.000648	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Meropenem—Oedema—Docetaxel—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Meropenem—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—pancreatic cancer	0.000641	0.000641	CcSEcCtD
Meropenem—Pruritus—Gemcitabine—pancreatic cancer	0.000641	0.000641	CcSEcCtD
Meropenem—Infection—Docetaxel—pancreatic cancer	0.000638	0.000638	CcSEcCtD
Meropenem—Diarrhoea—Irinotecan—pancreatic cancer	0.000636	0.000636	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—pancreatic cancer	0.000634	0.000634	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—pancreatic cancer	0.000632	0.000632	CcSEcCtD
Meropenem—Shock—Docetaxel—pancreatic cancer	0.000632	0.000632	CcSEcCtD
Meropenem—Nervous system disorder—Docetaxel—pancreatic cancer	0.00063	0.00063	CcSEcCtD
Meropenem—Pruritus—Fluorouracil—pancreatic cancer	0.00063	0.00063	CcSEcCtD
Meropenem—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000629	0.000629	CcSEcCtD
Meropenem—Infestation—Doxorubicin—pancreatic cancer	0.000629	0.000629	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—pancreatic cancer	0.000629	0.000629	CcSEcCtD
Meropenem—Tachycardia—Docetaxel—pancreatic cancer	0.000627	0.000627	CcSEcCtD
Meropenem—Skin disorder—Docetaxel—pancreatic cancer	0.000624	0.000624	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000623	0.000623	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—pancreatic cancer	0.000621	0.000621	CcSEcCtD
Meropenem—Diarrhoea—Gemcitabine—pancreatic cancer	0.000619	0.000619	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—pancreatic cancer	0.000618	0.000618	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000616	0.000616	CcSEcCtD
Meropenem—Dizziness—Irinotecan—pancreatic cancer	0.000615	0.000615	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—pancreatic cancer	0.000613	0.000613	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—pancreatic cancer	0.000613	0.000613	CcSEcCtD
Meropenem—Anorexia—Docetaxel—pancreatic cancer	0.000612	0.000612	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—pancreatic cancer	0.00061	0.00061	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—pancreatic cancer	0.00061	0.00061	CcSEcCtD
Meropenem—Diarrhoea—Fluorouracil—pancreatic cancer	0.000609	0.000609	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—pancreatic cancer	0.000605	0.000605	CcSEcCtD
Meropenem—Sweating—Doxorubicin—pancreatic cancer	0.000603	0.000603	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—pancreatic cancer	0.000601	0.000601	CcSEcCtD
Meropenem—Hypotension—Docetaxel—pancreatic cancer	0.0006	0.0006	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000595	0.000595	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—pancreatic cancer	0.000593	0.000593	CcSEcCtD
Meropenem—Vomiting—Irinotecan—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Meropenem—Dizziness—Fluorouracil—pancreatic cancer	0.000589	0.000589	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000587	0.000587	CcSEcCtD
Meropenem—Rash—Irinotecan—pancreatic cancer	0.000586	0.000586	CcSEcCtD
Meropenem—Dermatitis—Irinotecan—pancreatic cancer	0.000585	0.000585	CcSEcCtD
Meropenem—Headache—Irinotecan—pancreatic cancer	0.000582	0.000582	CcSEcCtD
Meropenem—Insomnia—Docetaxel—pancreatic cancer	0.000581	0.000581	CcSEcCtD
Meropenem—Paraesthesia—Docetaxel—pancreatic cancer	0.000577	0.000577	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—pancreatic cancer	0.000577	0.000577	CcSEcCtD
Meropenem—Vomiting—Gemcitabine—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—pancreatic cancer	0.000575	0.000575	CcSEcCtD
Meropenem—Dyspnoea—Docetaxel—pancreatic cancer	0.000573	0.000573	CcSEcCtD
Meropenem—Somnolence—Docetaxel—pancreatic cancer	0.000571	0.000571	CcSEcCtD
Meropenem—Rash—Gemcitabine—pancreatic cancer	0.000571	0.000571	CcSEcCtD
Meropenem—Dermatitis—Gemcitabine—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—pancreatic cancer	0.000567	0.000567	CcSEcCtD
Meropenem—Headache—Gemcitabine—pancreatic cancer	0.000567	0.000567	CcSEcCtD
Meropenem—Vomiting—Fluorouracil—pancreatic cancer	0.000566	0.000566	CcSEcCtD
Meropenem—Dyspepsia—Docetaxel—pancreatic cancer	0.000566	0.000566	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—pancreatic cancer	0.000564	0.000564	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—pancreatic cancer	0.000564	0.000564	CcSEcCtD
Meropenem—Rash—Fluorouracil—pancreatic cancer	0.000561	0.000561	CcSEcCtD
Meropenem—Dermatitis—Fluorouracil—pancreatic cancer	0.000561	0.000561	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—pancreatic cancer	0.00056	0.00056	CcSEcCtD
Meropenem—Decreased appetite—Docetaxel—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Meropenem—Headache—Fluorouracil—pancreatic cancer	0.000558	0.000558	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000556	0.000556	CcSEcCtD
Meropenem—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000555	0.000555	CcSEcCtD
Meropenem—Nausea—Irinotecan—pancreatic cancer	0.000552	0.000552	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—pancreatic cancer	0.000551	0.000551	CcSEcCtD
Meropenem—Constipation—Docetaxel—pancreatic cancer	0.000549	0.000549	CcSEcCtD
Meropenem—Pain—Docetaxel—pancreatic cancer	0.000549	0.000549	CcSEcCtD
Meropenem—Chills—Epirubicin—pancreatic cancer	0.000547	0.000547	CcSEcCtD
Meropenem—Nausea—Gemcitabine—pancreatic cancer	0.000538	0.000538	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000534	0.000534	CcSEcCtD
Meropenem—Erythema—Epirubicin—pancreatic cancer	0.000531	0.000531	CcSEcCtD
Meropenem—Feeling abnormal—Docetaxel—pancreatic cancer	0.000529	0.000529	CcSEcCtD
Meropenem—Nausea—Fluorouracil—pancreatic cancer	0.000529	0.000529	CcSEcCtD
Meropenem—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000525	0.000525	CcSEcCtD
Meropenem—Flatulence—Epirubicin—pancreatic cancer	0.000523	0.000523	CcSEcCtD
Meropenem—Tension—Epirubicin—pancreatic cancer	0.000521	0.000521	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—pancreatic cancer	0.00052	0.00052	CcSEcCtD
Meropenem—Nervousness—Epirubicin—pancreatic cancer	0.000516	0.000516	CcSEcCtD
Meropenem—Back pain—Epirubicin—pancreatic cancer	0.000514	0.000514	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—pancreatic cancer	0.00051	0.00051	CcSEcCtD
Meropenem—Body temperature increased—Docetaxel—pancreatic cancer	0.000508	0.000508	CcSEcCtD
Meropenem—Abdominal pain—Docetaxel—pancreatic cancer	0.000508	0.000508	CcSEcCtD
Meropenem—Chills—Doxorubicin—pancreatic cancer	0.000506	0.000506	CcSEcCtD
Meropenem—Erythema—Doxorubicin—pancreatic cancer	0.000491	0.000491	CcSEcCtD
Meropenem—Anaemia—Epirubicin—pancreatic cancer	0.000491	0.000491	CcSEcCtD
Meropenem—Agitation—Epirubicin—pancreatic cancer	0.000488	0.000488	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—pancreatic cancer	0.000484	0.000484	CcSEcCtD
Meropenem—Tension—Doxorubicin—pancreatic cancer	0.000482	0.000482	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—pancreatic cancer	0.000481	0.000481	CcSEcCtD
Meropenem—Malaise—Epirubicin—pancreatic cancer	0.000479	0.000479	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—pancreatic cancer	0.000477	0.000477	CcSEcCtD
Meropenem—Syncope—Epirubicin—pancreatic cancer	0.000476	0.000476	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—pancreatic cancer	0.000475	0.000475	CcSEcCtD
Meropenem—Back pain—Doxorubicin—pancreatic cancer	0.000475	0.000475	CcSEcCtD
Meropenem—Hypersensitivity—Docetaxel—pancreatic cancer	0.000473	0.000473	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—pancreatic cancer	0.000467	0.000467	CcSEcCtD
Meropenem—Cough—Epirubicin—pancreatic cancer	0.000463	0.000463	CcSEcCtD
Meropenem—Asthenia—Docetaxel—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Meropenem—Hypertension—Epirubicin—pancreatic cancer	0.000458	0.000458	CcSEcCtD
Meropenem—Pruritus—Docetaxel—pancreatic cancer	0.000455	0.000455	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—pancreatic cancer	0.000454	0.000454	CcSEcCtD
Meropenem—Chest pain—Epirubicin—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Meropenem—Agitation—Doxorubicin—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Meropenem—Anxiety—Epirubicin—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000449	0.000449	CcSEcCtD
Meropenem—Malaise—Doxorubicin—pancreatic cancer	0.000443	0.000443	CcSEcCtD
Meropenem—Syncope—Doxorubicin—pancreatic cancer	0.000441	0.000441	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—pancreatic cancer	0.00044	0.00044	CcSEcCtD
Meropenem—Diarrhoea—Docetaxel—pancreatic cancer	0.00044	0.00044	CcSEcCtD
Meropenem—Confusional state—Epirubicin—pancreatic cancer	0.000437	0.000437	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000433	0.000433	CcSEcCtD
Meropenem—Oedema—Epirubicin—pancreatic cancer	0.000433	0.000433	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000432	0.000432	CcSEcCtD
Meropenem—Infection—Epirubicin—pancreatic cancer	0.000431	0.000431	CcSEcCtD
Meropenem—Cough—Doxorubicin—pancreatic cancer	0.000429	0.000429	CcSEcCtD
Meropenem—Shock—Epirubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—pancreatic cancer	0.000425	0.000425	CcSEcCtD
Meropenem—Dizziness—Docetaxel—pancreatic cancer	0.000425	0.000425	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000424	0.000424	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—pancreatic cancer	0.000424	0.000424	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—pancreatic cancer	0.000423	0.000423	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—pancreatic cancer	0.000421	0.000421	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000419	0.000419	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—pancreatic cancer	0.000418	0.000418	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—pancreatic cancer	0.000417	0.000417	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000415	0.000415	CcSEcCtD
Meropenem—Anorexia—Epirubicin—pancreatic cancer	0.000413	0.000413	CcSEcCtD
Meropenem—Vomiting—Docetaxel—pancreatic cancer	0.000409	0.000409	CcSEcCtD
Meropenem—Rash—Docetaxel—pancreatic cancer	0.000405	0.000405	CcSEcCtD
Meropenem—Hypotension—Epirubicin—pancreatic cancer	0.000405	0.000405	CcSEcCtD
Meropenem—Dermatitis—Docetaxel—pancreatic cancer	0.000405	0.000405	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—pancreatic cancer	0.000404	0.000404	CcSEcCtD
Meropenem—Headache—Docetaxel—pancreatic cancer	0.000403	0.000403	CcSEcCtD
Meropenem—Oedema—Doxorubicin—pancreatic cancer	0.000401	0.000401	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000401	0.000401	CcSEcCtD
Meropenem—Infection—Doxorubicin—pancreatic cancer	0.000398	0.000398	CcSEcCtD
Meropenem—Shock—Doxorubicin—pancreatic cancer	0.000395	0.000395	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000393	0.000393	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000393	0.000393	CcSEcCtD
Meropenem—Insomnia—Epirubicin—pancreatic cancer	0.000392	0.000392	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—pancreatic cancer	0.000391	0.000391	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000388	0.000388	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—pancreatic cancer	0.000386	0.000386	CcSEcCtD
Meropenem—Somnolence—Epirubicin—pancreatic cancer	0.000385	0.000385	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—pancreatic cancer	0.000382	0.000382	CcSEcCtD
Meropenem—Nausea—Docetaxel—pancreatic cancer	0.000382	0.000382	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—pancreatic cancer	0.000377	0.000377	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—pancreatic cancer	0.000375	0.000375	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000374	0.000374	CcSEcCtD
Meropenem—Constipation—Epirubicin—pancreatic cancer	0.000371	0.000371	CcSEcCtD
Meropenem—Pain—Epirubicin—pancreatic cancer	0.000371	0.000371	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—pancreatic cancer	0.000363	0.000363	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—pancreatic cancer	0.000357	0.000357	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—pancreatic cancer	0.000357	0.000357	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—pancreatic cancer	0.000356	0.000356	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000354	0.000354	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—pancreatic cancer	0.000353	0.000353	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—pancreatic cancer	0.000349	0.000349	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000346	0.000346	CcSEcCtD
Meropenem—Urticaria—Epirubicin—pancreatic cancer	0.000344	0.000344	CcSEcCtD
Meropenem—Constipation—Doxorubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Meropenem—Pain—Doxorubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00033	0.00033	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000328	0.000328	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—pancreatic cancer	0.000319	0.000319	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—pancreatic cancer	0.000319	0.000319	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—pancreatic cancer	0.000317	0.000317	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—pancreatic cancer	0.000317	0.000317	CcSEcCtD
Meropenem—Asthenia—Epirubicin—pancreatic cancer	0.000311	0.000311	CcSEcCtD
Meropenem—Pruritus—Epirubicin—pancreatic cancer	0.000307	0.000307	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—pancreatic cancer	0.000297	0.000297	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000295	0.000295	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—pancreatic cancer	0.000288	0.000288	CcSEcCtD
Meropenem—Dizziness—Epirubicin—pancreatic cancer	0.000287	0.000287	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—pancreatic cancer	0.000284	0.000284	CcSEcCtD
Meropenem—Vomiting—Epirubicin—pancreatic cancer	0.000276	0.000276	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—pancreatic cancer	0.000274	0.000274	CcSEcCtD
Meropenem—Rash—Epirubicin—pancreatic cancer	0.000273	0.000273	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—pancreatic cancer	0.000273	0.000273	CcSEcCtD
Meropenem—Headache—Epirubicin—pancreatic cancer	0.000271	0.000271	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—pancreatic cancer	0.000265	0.000265	CcSEcCtD
Meropenem—Nausea—Epirubicin—pancreatic cancer	0.000257	0.000257	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—pancreatic cancer	0.000255	0.000255	CcSEcCtD
Meropenem—Rash—Doxorubicin—pancreatic cancer	0.000253	0.000253	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—pancreatic cancer	0.000253	0.000253	CcSEcCtD
Meropenem—Headache—Doxorubicin—pancreatic cancer	0.000251	0.000251	CcSEcCtD
Meropenem—Nausea—Doxorubicin—pancreatic cancer	0.000238	0.000238	CcSEcCtD
